Skip to main content

Table 5 Mean number of daily doses taken by patients in the three clinical studies according to their previous experience of cannabis

From: Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach

Study

 

Prior Cannabis

n

Mean daily doses

SD

GWCL0403

Sativex®

PC

33

8.47

5.06

  

No PC

133

8.49

4.70

 

Placebo

PC

47

14.69

6.34

  

No PC

122

15.67

6.08

GWMS0001

Sativex®

PC

33

13.78

10.2

  

No PC

37

13.27

7.66

 

Placebo

PC

32

21.72

11.15

  

No PC

30

24.75

10.83

GWMS0106

Sativex®

PC

51

8.97

7.04

  

No PC

69

9.79

6.02

 

Placebo

PC

27

15.83

9.37

  

No PC

37

14.70

7.59